COVID tests detect the virus in one of three ways: by finding its genetic material, by finding proteins on its surface, or by finding antibodies your immune system made in response to it. The first two types tell you if you’re currently infected. The third tells you if you were infected (or vaccinated) in the past. Which test you use, how you collect your sample, and when you test all affect how reliable your result is.
PCR Tests: Amplifying Viral Genetic Material
PCR tests (also called molecular tests) are the most sensitive COVID tests available. They work by taking a tiny amount of viral genetic material from your sample and copying it millions of times until there’s enough to measure. The virus that causes COVID uses RNA as its genetic code, so the process starts by converting that RNA into DNA, a step called reverse transcription. This is why you’ll sometimes see these called RT-PCR tests.
Once the RNA has been converted to DNA, the test enters a repeating cycle. First, the two strands of the DNA are separated by heat. Then small pieces of synthetic DNA called primers attach to the viral sequence. These primers are designed to match only SARS-CoV-2, so human DNA and other viruses in your sample get ignored. New DNA strands are built along the template, and fluorescent dyes attach to the newly created copies, producing a glow that the machine can measure. This cycle repeats 20 to 30 times, creating hundreds of copies of the original viral sequence.
The machine tracks how many cycles it takes for the fluorescent signal to become detectable. This number is called the cycle threshold, or Ct value. A low Ct (fewer cycles needed) means there was a lot of virus in your sample, which typically suggests higher infectivity. A high Ct means less virus was present. Most labs consider a Ct above a certain cutoff as a positive result, though the exact threshold varies. Because PCR is so sensitive, it can sometimes detect residual genetic fragments weeks after you’ve stopped being contagious.
Rapid Antigen Tests: Catching Viral Proteins
Rapid antigen tests, the kind most people use at home, work on an entirely different principle. Instead of looking for genetic material, they look for proteins sitting on the surface of the virus. The most common target is the nucleocapsid protein, which wraps around the virus’s RNA core.
The mechanism is surprisingly simple. When you swab your nose and mix the sample with the liquid buffer, then drip it onto the test strip, the liquid moves across a porous pad through capillary action, the same force that pulls water up a paper towel. As the liquid flows, it encounters antibodies embedded on the strip that are designed to bind only to the SARS-CoV-2 protein. If viral proteins are present, they latch onto these antibodies at the test line, producing a visible colored band. A second “control” line uses a different reaction to confirm the test worked properly.
This process takes about 15 minutes, compared to hours or even days for a PCR result from a lab. The tradeoff is sensitivity. In a CDC study from 2022 to 2023, antigen tests detected only 47% of infections that PCR confirmed, though that number jumped to 80% when the comparison was limited to samples containing live, culturable virus. In other words, antigen tests are better at catching infections when you’re most contagious, and worse at detecting very early or very late infections with low viral loads. On days when people reported no symptoms at all, sensitivity dropped to just 18% compared to PCR.
Symptoms make a big difference. When any COVID symptoms were present on the day of testing, sensitivity rose to 56% against PCR. On days when fever was reported, it peaked at 77%. This is why a single negative rapid test doesn’t rule out infection, especially if you feel fine.
Why Swab Technique and Location Matter
Where you collect your sample affects accuracy more than most people realize. Research from CIDRAP found that when healthcare workers collected specimens, throat swabs actually had higher sensitivity on rapid antigen tests than nasal swabs (69.4% versus 60.0%). But when people collected their own samples, the pattern flipped for symptomatic individuals: self-collected nose swabs outperformed self-collected throat swabs (71.5% versus 58.0%), likely because swabbing your own throat correctly is harder than it sounds.
The most notable finding: using both a nasal and throat swab together boosted sensitivity by 15 to 21 percentage points compared to a nose swab alone. Some countries have recommended this combined approach for at-home testing, though most test kit instructions in the U.S. still specify nasal swabs only. Following the instructions included with your specific test is important, since the test was validated using that particular collection method.
When to Test After Exposure
Timing is one of the biggest factors in getting an accurate result. The FDA recommends waiting at least five full days after exposure before testing with an at-home antigen test if you have no symptoms. Testing too soon often produces a false negative because the virus hasn’t replicated enough to be detectable. Even after that waiting period, it can take two to five days (sometimes longer) for antigen levels to rise high enough for a rapid test to pick up.
PCR tests can detect infection slightly earlier than antigen tests because they amplify tiny amounts of genetic material, but even PCR has limits in the first day or two after exposure. If you develop symptoms, test right away regardless of when exposure happened, since symptoms usually mean the virus is actively replicating.
Serial Testing Reduces False Negatives
A single negative rapid test is not especially reliable on its own. The FDA’s current guidance for most at-home antigen tests says you should repeat testing after a negative result whether or not you have symptoms. For people without symptoms, the recommended protocol is three tests over five days. This serial approach compensates for the test’s lower sensitivity by catching the infection as viral load rises over consecutive days.
If your first test is negative but you develop symptoms a day or two later, test again. A negative-then-positive pattern is common, particularly with newer variants that may take slightly longer to reach detectable levels in the nose.
Antibody Tests Serve a Different Purpose
Antibody tests don’t tell you if you’re currently infected. They check whether your immune system has produced antibodies against the virus, which means you either had a past infection or received a COVID vaccine. These tests use a blood sample rather than a nasal swab and are primarily used for surveillance and research purposes, not for diagnosing active illness.
How Variants Affect Test Reliability
As SARS-CoV-2 mutates, there’s always a question of whether existing tests still work. Most rapid antigen tests target the nucleocapsid protein, which mutates less frequently than the spike protein. Still, some mutations have caused problems with specific tests. The FDA flagged that a nucleocapsid mutation called E136D, found in the BE.1 and BQ.1 Omicron subvariants, impacted performance of at least one authorized rapid test. Mutations associated with BA.1 and BA.2 Omicron subvariants affected another. The FDA maintains a running list of tests with known vulnerability to specific mutations, and manufacturers are expected to update their products accordingly.
PCR tests are less vulnerable to variant changes because they can target multiple gene regions simultaneously. If one target is affected by a mutation, others still detect the virus. This built-in redundancy is one reason PCR remains the gold standard for confirming infection when accuracy matters most.